Amgen 2025 Wells Fargo Healthcare Conference Presentation
amgen’s Chief Medical Officer to Address Wells Fargo Healthcare Conference
Thousand Oaks, CA, August 29, 2025 – Amgen (NASDAQ:AMGN), a pioneering biotechnology firm dedicated to developing innovative medicines, will be presenting at the upcoming Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 10:15 a.m. ET. Dr. Paul Burton,Amgen’s esteemed Senior Vice President and Chief Medical Officer,will be the featured speaker.
This presentation offers a valuable opportunity for investors, members of the news media, and the general public to gain insights into Amgen’s latest advancements and strategic direction. A live webcast of the presentation will be available on Amgen’s website (www.amgen.com) under the “Investors” section.The webcast will be archived for at least 90 days following the event, ensuring accessibility for those unable to attend the live broadcast.
Amgen has been at the forefront of biotechnology for over 40 years, consistently pushing the boundaries of scientific innovation to address some of the world’s most challenging diseases. The company’s commitment to using technology and human genetic data has led to breakthroughs in the treatment of cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.
Amgen’s dedication to innovation and employee well-being has earned the company numerous accolades. In 2024, Amgen was recognized as one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. As one of the 30 companies comprising the Dow Jones Industrial Average®, Amgen continues to be a leader in the biotechnology industry, driving progress and improving the lives of millions of patients worldwide.